Related Experiment Videos
Primary thrombophilia in Mexico: a prospective study
G J Ruiz-Argüelles1, S González-Estrada, J Garcés-Eisele
1Centro de Hematología y Medicina Interna de Puebla, Mexico.
American Journal of Hematology
|January 12, 1999
Summary
This study found low rates of genetic thrombophilia markers, like activated protein C resistance, in Mexican Mestizo patients. These findings suggest a unique genetic profile for thrombophilia in this population.
Area of Science:
- Hematology
- Genetics
- Thrombophilia
Background:
- Primary thrombophilia involves inherited or acquired conditions increasing blood clot risk.
- Understanding the genetic basis of thrombophilia is crucial for risk assessment and prevention.
Purpose of the Study:
- To investigate the prevalence of inherited thrombophilia risk factors in Mexican Mestizo patients.
- To identify specific genetic mutations associated with thrombophilia in this cohort.
Main Methods:
- Prospective study of 102 Mexican Mestizo patients with clinical suspicion of primary thrombophilia.
- Screening for activated protein C resistance, factor V Leiden mutation, protein C deficiency, and protein S deficiency.
- Assessment of other coagulation factors including antithrombin III and plasminogen.
Main Results:
- 39% of patients exhibited activated protein C resistance, but only 4 had the factor V Leiden mutation.
- 5% were protein C deficient, and 2% were protein S deficient.
- No abnormalities were detected in antithrombin III, plasminogen, tissue-type plasminogen activator, or plasminogen activator inhibitor.
Conclusions:
- The prevalence of activated protein C resistance genotype is notably low in this Mexican Mestizo cohort.
- Genetic admixture likely influences the observed low prevalence of specific thrombophilia markers.
- Further research is needed to fully elucidate thrombophilia genetics in diverse populations.